简体中文 | 繁體中文 | English

Advisory/Reminders News

2016-07-25 14:55 Octapharma to Sponsor Two Symposia at the 2016 World Federation of Hemophilia (WFH) World Congress in Orlando, USA
2016-07-25 14:04 ADDING and REPLACING Joy Global Announces Agreement to Be Acquired by Komatsu in $3.7 Billion All-Cash Transaction
2016-07-25 10:20 Starpharma Signs License for a VivaGel® Condom in China
2016-07-25 09:59 Grand River Development Limited -Redefining Taipei’s Skyline
2016-07-22 17:58 The University of Tokyo Selects Mellanox EDR InfiniBand to Accelerate its Newest Supercomputer
2016-07-22 16:57 Music Festival Toward the Realization of "International Peace Hiroshima-Based Concept"
2016-07-22 16:38 Guillaume Jesel Promoted to Global Brand President, TOM FORD BEAUTY
2016-07-22 15:16 SES Enhances Quality of Healthcare in the Philippines Through SATMED E-Health Platform
2016-07-22 14:30 Hoshino Resorts Opens the Capital's First Luxury Ryokan, HOSHINOYA Tokyo in July, 2016
2016-07-22 13:53 Visa Adds Refugee Olympic Athletes to Complete Team Visa Rio 2016 Roster
2016-07-22 10:20 Momentive Performance Materials to Showcase Wide Variety of New Niax* Additives at PU China 2016
2016-07-22 09:51 Egis’ Fingerprint Sensor, ET320, Selected for Samsung Galaxy C7
2016-07-21 17:37 Greene, Tweed’s Arlon® 3000 XT Displays Unparalleled High Voltage Resistivity
2016-07-21 16:53 Limelight Helps Channel 4 Deliver Broadcast Quality Programs On-Demand
2016-07-21 16:13 Dr. Andreas Haldi Joins CYNORA GmbH as Chief Marketing Officer
2016-07-21 15:48 SES Connects Multi-Country Music Festival “Tomorrowland 2016 UNITE” via Satellites
2016-07-21 15:03 The Estée Lauder Companies Announces Executive Leadership Team Updates
2016-07-21 14:35 The Republic of Mali Chooses OT to Supply Its Latest Generation Electronic Passport
2016-07-21 13:54 South Korea without Fail Facial Contouring Plastic Surgery Expertise
2016-07-21 11:58 Seattle Genetics and Takeda Announce Publication of Final Data from ADCETRIS® (Brentuximab Vedotin) Monotherapy Pivotal Phase 2 Clinical Trial in Relapsed or Refractory Classical Hodgkin Lymphoma in Blood

Business Wire Weibo

Press Releases

Latest Releases